The Food and Drug Administration is considering letting some women with breast cancer try out experimental drugs earlier in the course of the disease, when they have a better chance of being helped, Reuters reports.
Currently, the newest drugs are tried first on people in latest stages of disease. But Dr. Richard Pazdur, director of the FDA's cancer drug office, said the agency may let women with early stage disease test some of the new drugs.
"We're looking at introducing drugs into a very early stage of breast cancer, where a patient has a primary tumor and the chemotherapy is given before surgery," Pazdur said at the American Society of Clinical Oncology meeting in Chicago.
Get the latest news and analysis delivered to your inbox. Sign up for National Journal's morning alert, Wake-Up Call, and afternoon newsletter, The Edge. Subscribe here.
Leave A Comment